Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
LGALS9 was initially thought to represent a pseudogene of galectin 9; however, this transcript has good exon-intron structure and encodes a predicted protein of the same size as and highly similar to galectin 9. De plus, nous expédions Lectin, Galactoside-Binding, Soluble, 9 Kits (63) et Lectin, Galactoside-Binding, Soluble, 9 Protéines (41) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 206 products:
Mouse (Murine) Polyclonal LGALS9 Primary Antibody pour CyTOF, FACS - ABIN4899254
Iqbal, Sampaio, Maione, Greco, Niki, Hirashima, Perretti, Cooper: Endogenous galectin-1 and acute inflammation: emerging notion of a galectin-9 pro-resolving effect. dans The American journal of pathology 2011
Show all 4 Pubmed References
Human Polyclonal LGALS9 Primary Antibody pour ELISA, WB - ABIN561667
Bellac, Coimbra, Simon, Imboden, Leib: Gene and protein expression of galectin-3 and galectin-9 in experimental pneumococcal meningitis. dans Neurobiology of disease 2007
Show all 2 Pubmed References
Human Polyclonal LGALS9 Primary Antibody pour IF (p), IHC (p) - ABIN733163
Daley, Mani, Mohan, Akkad, Ochi, Heindel, Lee, Zambirinis, Pandian, Savadkar, Torres-Hernandez, Nayak, Wang, Hundeyin, Diskin, Aykut, Werba, Barilla, Rodriguez, Chang, Gardner, Mahal, Ueberheide et al.: Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. ... dans Nature medicine 2017
Gal9 may be a new immunomodulatory target for macrophages.
these findings reveal a critical role for Tim-3 (Montrer HAVCR2 Anticorps)-Gal-9 signaling-mediated immunoregulation by pNK (Montrer PNKP Anticorps) cells in maternal-fetal immune tolerance and suggest that Tim-3 (Montrer HAVCR2 Anticorps) abundance on pNK (Montrer PNKP Anticorps) cells is a potential biomarker for recurrent miscarriage diagnosis.
in a model of experimental autoimmune encephalomyelitis, we show that an agonist of DR3 (Montrer TNFRSF25 Anticorps) suppressed disease, correlating with expansion of CD4 (Montrer CD4 Anticorps)+Foxp3 (Montrer FOXP3 Anticorps)+ Tregs, and this protective effect was lost in Galectin-9-/- mice
Galectin 9 is a novel dectin 1 (Montrer CLEC7A Anticorps) ligand in pancreatic ductal adenocarcinoma. Upon disruption of the dectin 1 (Montrer CLEC7A Anticorps)-galectin 9 axis, CD4 (Montrer CD4 Anticorps)(+) and CD8 (Montrer CD8A Anticorps)(+) T cells, which are dispensable for PDA progression in hosts with an intact signaling axis, become reprogrammed into indispensable mediators of anti-tumor immunity.
The Gal-9/Tim-3 (Montrer HAVCR2 Anticorps) signal is important for the regulation of decidua NK cells function, which is beneficial for the maintenance of a normal pregnancy.
These results indicate the possibility that cooperative binding of oligosaccharide and neighboring polypeptide structures of monoclonal IgE to galectin-9 affects the overall affinity and specificity of the IgE-lectin interaction.
galectin-9 functions as a novel alarmin by augmenting the inflammatory response in sepsis development during pulmonary F. novicida infection.
Gal-9 has a role in the maintenance of hepatic homeostasis and preventing liver ischemia-reperfusion injury
Gal-9, a natural TIM-3 (Montrer HAVCR2 Anticorps) ligand, was produced primarily by and released from ischemia-reperfusion-stressed hepatocytes, both in vivo and in vitro.
Galectin-9 functions as an astrocyte-microglia communication signal and promotes cytokine production from microglia in a Tim-3 (Montrer HAVCR2 Anticorps) independent manner.
Gal-9 expression determined the DFS (Montrer FST Anticorps) and OS of ovarian cancer patients in two opposing ways-moderate Gal-9 expression was correlated with a reduced outcome as compared to Gal-9 negative cases, while patients with high Gal-9 expression showed the best outcome.
these data indicate a novel role for galectin-9 in modulating innate immunity by inducing aldehyde dehydrogenase activity in CD103 (Montrer ITGAE Anticorps)+ dendritic cells
Gal-9 was down modulated in stroma of patients with chronic gastritis and Helicobacter pylori infection.
T-cell immunoglobulin mucin-3 (Montrer HAVCR2 Anticorps)/galectin-9 (Tim-3 (Montrer HAVCR2 Anticorps)/Gal-9) binding signaling can also engage other binding partners to induce distinct cellular responses [Review].
the present study was the first to report the participation of Gal-9 in Chagas disease
The interaction between Gal-9/TIM-3 (Montrer HAVCR2 Anticorps) pathway and follicular helper cells contributed to viral persistent in chronic hepatitis C virus infection.
Our data reveal that Gal9 suppresses the growth of liver metastasis, possibly by inducing apoptosis through a mechanism involving mitochondria and changes in miRNA expression. Thus, Gal9 might serve as a therapeutic agent for the treatment of liver metastasis from pancreatic cancer.
Exosomal total protein, Tim-3 (Montrer HAVCR2 Anticorps) and Galectin-9 were up-regulated in non-small cell lung cancer plasma.
Galectin-9, a soluble lectin expressed by T cells, endothelial cells and dendritic cells, binds to and retains PDI (Montrer PADI1 Anticorps) on the cell surface.
results suggested that Tim-3 (Montrer HAVCR2 Anticorps) and Gal-9 could downregulate T cell inflammation in Osteoarthritis
The Tim-3 (Montrer HAVCR2 Anticorps)/Gal-9 pathway might link disease progression with T cell exhaustion during bovine leukemia virus infection.
The relative abundance of PIBF (Montrer PIBF1 Anticorps), LGALS1 (Montrer LGALS1 Anticorps), LGALS3 (Montrer LGALS2 Anticorps), LGALS3BP (Montrer LGALS3BP Anticorps), and LGALS9 mRNA would display a differential expression pattern in the endometrium.
The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. The protein encoded by this gene is an S-type lectin. It is overexpressed in Hodgkin's disease tissue and might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its associated immunodeficiency. Multiple alternatively spliced transcript variants have been found for this gene.
lectin, galactoside-binding, soluble, 9
, galactoside-binding soluble lectin 9
, galectin 9
, lectin, galactoside-binding, soluble, 9 (galectin 9)
, lectin, galactose binding, soluble 5
, tumor antigen HOM-HD-21
, urate transporter/channel protein
, 36 kDa beta-galactoside-binding lectin
, Lectin galactose binding soluble 9 (Galectin-9)
, Lectin, galactose binding, soluble 9 (Galectin-9)
, urate transporter/channel
, urate transporter
, urate transporter/channel protein, isoform (UATp,i)